Influence of body mass index, cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic cirrhosis.
Authors:
- Gianni TestinoGTGianni Testino
- Alessandro SumberazASAlessandro Sumberaz
- A Ornella AncaraniAAA Ornella Ancarani
- Paolo BorroPBPaolo Borro
- Gianluigi RavettiGRGianluigi Ravetti
- Filippo AnsaldiFAFilippo Ansaldi
- Enzo AndornoEAEnzo Andorno
- Raffaella GentileRGRaffaella Gentile
- Giancarlo IcardiGIGiancarlo Icardi
- 8 July 2009
- journal article
- Vol. 56 (90) , 501-3